ITERUM THERAPEUTICS PLC (ITRM)

IE000TTOOBX0 - Common Stock

1.98  +0.08 (+4.21%)

After market: 1.99 +0.01 (+0.51%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
26.46M47.47M30.38M24.54M32.12M
Research and Development
18.90M39.99M17.62M10.71M21.07M
Selling, General, and Administrative Expenses
7.55M7.48M12.77M13.83M11.05M
Operating Income
-26.46M-47.47M-30.38M-24.54M-32.12M
Interest Income/Expense
-3.58M9.63M3.10M-66.52M-16.84M
Other Income/Expense
-156.00K82.00K500.00K200.00K210.00K
Non Recurring Items
N/A0.00-17.35M0.00-2.51M
Income Before Taxes
-30.20M-37.76M-44.13M-90.86M-51.26M
Income Tax
357.00K613.00K300.00K710.00K740.00K
Net Income
-30.55M-38.37M-44.43M-91.56M-52.01M
EBITDA
-25.99M-45.72M-28.58M-22.44M-31.96M
 
Per Share Data
EPS Diluted Total Ops
-2.00-2.96-3.63-8.41-32.49
Non GAAP EPS
-2.00N/A-2.28-11.55-38.55
 
Statistics
Profit Margin
N/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/A

All data in USD

Charts